Dr. Tricia Marie Russell is a pharmacist who is specialized in Pharmacotherapy in Scranton, Pennsylvania. Patients can reach her at 125 Scranton Pocono Hwy, Scranton or contact her on 570-342-8500. Active license number of Dr. Tricia Marie Russell is RP039456T for Pharmacotherapy in Pennsylvania. Dr. Tricia Marie Russell is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Tricia Marie Russell speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Tricia Marie Russell are as mentioned below.
NPI Number:
1811021801
NPI Enumeration Date:
14 Mar, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Tricia Marie Russell are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
RP039456T
Pennsylvania
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
477 Strawberry Ln, Mountain Top, Pennsylvania
Zip:
18707-1559
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Tricia Marie Russell at 125 Scranton Pocono Hwy, Scranton, Pennsylvania or can call on phone at 570-342-8500.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.